Download
s13613-021-00911-8.pdf 1,02MB
WeightNameValue
1000 Titel
  • Lactate is associated with mortality in very old intensive care patients suffering from COVID-19: results from an international observational study of 2860 patients
1000 Autor/in
  1. Bruno, Raphael Romano |
  2. Wernly, Bernhard |
  3. Flaatten, Hans |
  4. Fjølner, Jesper |
  5. Artigas, Antonio |
  6. Bollen Pinto, Bernardo |
  7. Schefold, Joerg C. |
  8. Binnebössel, Stephan |
  9. Baldia, Philipp Heinrich |
  10. Kelm, Malte |
  11. Beil, Michael |
  12. Sigal, Sivri |
  13. van Heerden, Peter Vernon |
  14. Szczeklik, Wojciech |
  15. Elhadi, Muhammed |
  16. Joannidis, Michael |
  17. Oeyen, Sandra |
  18. Zafeiridis, Tilemachos |
  19. Wollborn, Jakob |
  20. Arche Banzo, Maria José |
  21. Fuest, Kristina |
  22. Marsh, Brian |
  23. Andersen, Finn H. |
  24. Moreno, Rui |
  25. Leaver, Susannah |
  26. Boumendil, Ariane |
  27. De Lange, Dylan W. |
  28. Guidet, Bertrand |
  29. Jung, Christian |
1000 Mitwirkende/r
  1. COVIP Study Group |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-08-21
1000 Erschienen in
1000 Quellenangabe
  • 11(1):128
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13613-021-00911-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379577/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • PURPOSE: Lactate is an established prognosticator in critical care. However, there still is insufficient evidence about its role in predicting outcome in COVID-19. This is of particular concern in older patients who have been mostly affected during the initial surge in 2020. METHODS: This prospective international observation study (The COVIP study) recruited patients aged 70 years or older (ClinicalTrials.gov ID: NCT04321265) admitted to an intensive care unit (ICU) with COVID-19 disease from March 2020 to February 2021. In addition to serial lactate values (arterial blood gas analysis), we recorded several parameters, including SOFA score, ICU procedures, limitation of care, ICU- and 3-month mortality. A lactate concentration ≥ 2.0 mmol/L on the day of ICU admission (baseline) was defined as abnormal. The primary outcome was ICU-mortality. The secondary outcomes 30-day and 3-month mortality. RESULTS: In total, data from 2860 patients were analyzed. In most patients (68%), serum lactate was lower than 2 mmol/L. Elevated baseline serum lactate was associated with significantly higher ICU- and 3-month mortality (53% vs. 43%, and 71% vs. 57%, respectively, p < 0.001). In the multivariable analysis, the maximum lactate concentration on day 1 was independently associated with ICU mortality (aOR 1.06 95% CI 1.02–1.11; p = 0.007), 30-day mortality (aOR 1.07 95% CI 1.02–1.13; p = 0.005) and 3-month mortality (aOR 1.15 95% CI 1.08–1.24; p < 0.001) after adjustment for age, gender, SOFA score, and frailty. In 826 patients with baseline lactate ≥ 2 mmol/L sufficient data to calculate the difference between maximal levels on days 1 and 2 (∆ serum lactate) were available. A decreasing lactate concentration over time was inversely associated with ICU mortality after multivariate adjustment for SOFA score, age, Clinical Frailty Scale, and gender (aOR 0.60 95% CI 0.42–0.85; p = 0.004). CONCLUSION: In critically ill old intensive care patients suffering from COVID-19, lactate and its kinetics are valuable tools for outcome prediction.
1000 Sacherschließung
lokal Intensive / Critical Care Medicine
lokal Anesthesiology
lokal Emergency Medicine
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QnJ1bm8sIFJhcGhhZWwgUm9tYW5v|https://frl.publisso.de/adhoc/uri/V2Vybmx5LCBCZXJuaGFyZA==|https://frl.publisso.de/adhoc/uri/RmxhYXR0ZW4sIEhhbnM=|https://frl.publisso.de/adhoc/uri/RmrDuGxuZXIsIEplc3Blcg==|https://frl.publisso.de/adhoc/uri/QXJ0aWdhcywgQW50b25pbw==|https://frl.publisso.de/adhoc/uri/Qm9sbGVuIFBpbnRvLCBCZXJuYXJkbw==|https://frl.publisso.de/adhoc/uri/U2NoZWZvbGQsIEpvZXJnIEMu|https://frl.publisso.de/adhoc/uri/QmlubmViw7Zzc2VsLCBTdGVwaGFu|https://frl.publisso.de/adhoc/uri/QmFsZGlhLCBQaGlsaXBwIEhlaW5yaWNo|https://frl.publisso.de/adhoc/uri/S2VsbSwgTWFsdGU=|https://frl.publisso.de/adhoc/uri/QmVpbCwgTWljaGFlbA==|https://frl.publisso.de/adhoc/uri/U2lnYWwsIFNpdnJp|https://frl.publisso.de/adhoc/uri/dmFuIEhlZXJkZW4sIFBldGVyIFZlcm5vbg==|https://frl.publisso.de/adhoc/uri/U3pjemVrbGlrLCBXb2pjaWVjaA==|https://frl.publisso.de/adhoc/uri/RWxoYWRpLCBNdWhhbW1lZA==|https://frl.publisso.de/adhoc/uri/Sm9hbm5pZGlzLCBNaWNoYWVs|https://frl.publisso.de/adhoc/uri/T2V5ZW4sIFNhbmRyYQ==|https://frl.publisso.de/adhoc/uri/WmFmZWlyaWRpcywgVGlsZW1hY2hvcw==|https://frl.publisso.de/adhoc/uri/V29sbGJvcm4sIEpha29i|https://frl.publisso.de/adhoc/uri/QXJjaGUgQmFuem8sIE1hcmlhIEpvc8Op|https://frl.publisso.de/adhoc/uri/RnVlc3QsIEtyaXN0aW5h|https://frl.publisso.de/adhoc/uri/TWFyc2gsIEJyaWFu|https://frl.publisso.de/adhoc/uri/QW5kZXJzZW4sIEZpbm4gSC4=|https://frl.publisso.de/adhoc/uri/TW9yZW5vLCBSdWk=|https://frl.publisso.de/adhoc/uri/TGVhdmVyLCBTdXNhbm5haA==|https://frl.publisso.de/adhoc/uri/Qm91bWVuZGlsLCBBcmlhbmU=|https://frl.publisso.de/adhoc/uri/RGUgTGFuZ2UsIER5bGFuIFcu|https://frl.publisso.de/adhoc/uri/R3VpZGV0LCBCZXJ0cmFuZA==|https://orcid.org/0000-0001-8325-250X|https://frl.publisso.de/adhoc/uri/Q09WSVAgU3R1ZHkgR3JvdXA=
1000 Hinweis
  • DeepGreen-ID: ff33caa8c44c475aa419b7d5dcf3e3f8
1000 Label
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6442218.rdf
1000 Erstellt am 2023-04-26T13:31:48.843+0200
1000 Erstellt von 322
1000 beschreibt frl:6442218
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet Wed Oct 25 11:50:22 CEST 2023
1000 Objekt bearb. Wed Oct 25 11:49:51 CEST 2023
1000 Vgl. frl:6442218
1000 Oai Id
  1. oai:frl.publisso.de:frl:6442218 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source